To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SMEK1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
370 supporting clones for gene SMEK1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC022778 Skin, melanotic melanoma. .a 1 to 2951 1 to 2951   tiling clone, available from MGC, AAA   2951/2951
(100 %)
0 diff
(100 %id)
AB095930 brain .a 337 to 4441 1 to 4106 exact tiling clone, available from KIAA,   4106/4106
(100 %)
3 diff
(100.0 %id)
DR000530 fetal brain .a 585 to 1301 9 to 725       717/725
(98 %)
0 diff
(100 %id)
CR996278 T-Lymphocytes .a 672 to 1348 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BX429485 neuroblastoma .a 3175 to 3916 741 to 1       741/828
(89 %)
28 diff
(96.7 %id)
TI_149273446   .a 3182 to 4045 935 to 89   AAA   847/987
(85 %)
24 diff
(97.6 %id)
TI_154122670   .a 3184 to 3915 815 to 84   AAA   732/962
(76 %)
18 diff
(98.2 %id)
AF113213 aorta .a 3197 to 4441 1 to 1246   AAA   1246/1246
(100 %)
3 diff
(99.8 %id)
BF889170 testis_normal .a 3199 to 3515 324 to 8     Submitted on the opposite strand 317/343
(92 %)
0 diff
(100 %id)
TI_149288681   .a 3213 to 3915 785 to 83   AAA   703/704
(99 %)
3 diff
(99.6 %id)
EL733674 mixed .a 3217 to 3759 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
BF969847 adrenal cortex carcinoma, cell line, adrenal gland .a 3229 to 3950 1 to 722       722/946
(76 %)
8 diff
(99.2 %id)
BM970506 lung .a 3233 to 3915 701 to 19   AAA   683/683
(100 %)
3 diff
(99.6 %id)
TI_154020777   .a 3240 to 3915 770 to 95   AAA   676/677
(99 %)
7 diff
(99.0 %id)
W67211 heart .a 3264 to 3604 1 to 342   fully sequenced,   342/342
(100 %)
3 diff
(99.2 %id)
BX372760 Neuroblastoma Cot 25-normalized .a 3272 to 3909 645 to 5       641/693
(92 %)
0 diff
(100 %id)
BM824424 Ascites, stomach .a 3306 to 3915 1 to 610       610/610
(100 %)
0 diff
(100 %id)
TI_149303666   .a 3307 to 4045 823 to 86   tiling clone, AAA   738/938
(78 %)
3 diff
(99.7 %id)
N98829 multiple sclerosis lesions .a 3317 to 3458 1 to 158   fully sequenced,   158/158
(100 %)
1 diff
(99.4 %id)
CN479948 Chondrosarcoma, Left Pubic Bone .a 3328 to 3915 606 to 19   AAA   588/588
(100 %)
4 diff
(99.4 %id)
BM978670 lung, Primary Lung Epithelial Cells .a 3329 to 3915 604 to 19   AAA   586/586
(100 %)
2 diff
(99.7 %id)
BU675818 lung, Primary Lung Epithelial Cells .a 3346 to 4045 715 to 17   AAA   699/699
(100 %)
2 diff
(99.8 %id)
CA438621 lung, Metastatic Chondrosarcoma .a 3347 to 3915 588 to 19   AAA   570/570
(100 %)
2 diff
(99.7 %id)
BM981635 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3348 to 4045 714 to 17   AAA   698/698
(100 %)
0 diff
(100 %id)
BQ019216 lung, Metastatic Chondrosarcoma .a 3353 to 3915 582 to 19   AAA   564/564
(100 %)
1 diff
(99.9 %id)
TI_149276078   .a 3358 to 3916 732 to 171   AAA   562/1122
(50 %)
0 diff
(100 %id)
AA377370 small intestine .a 3391 to 3661 1 to 271       271/271
(100 %)
0 diff
(100 %id)
AW956350   .a 3392 to 3826 1 to 436       436/442
(98 %)
7 diff
(98.5 %id)
BP398410 pancreatic islet .a 3417 to 3915 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
TI_1948244868   .a 3417 to 4444 1204 to 191   AAA   1014/1408
(72 %)
0 diff
(100 %id)
AI817027 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 3419 to 3915 499 to 1       499/499
(100 %)
2 diff
(99.6 %id)
FN143739 breast carcinoma .a 3422 to 3517 95 to 3     Submitted on the opposite strand 93/95
(97 %)
0 diff
(100 %id)
N66569 multiple sclerosis lesions .a 3428 to 3910 484 to 1   fully sequenced,   484/484
(100 %)
3 diff
(99.4 %id)
TI_1948244343   .a 3443 to 4444 1191 to 190   tiling clone, AAA   1002/1386
(72 %)
0 diff
(100 %id)
AI467836 pooled .a 3444 to 3915 501 to 30   AAA   472/472
(100 %)
0 diff
(100 %id)
CA428964 Cell Line, Chondrosarcoma .a 3444 to 4052 619 to 12       608/619
(98 %)
0 diff
(100 %id)
AI889329 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3450 to 3916 492 to 26       467/492
(94 %)
0 diff
(100 %id)
BE535506 cervix .a 3462 to 4177 1 to 714       714/740
(96 %)
64 diff
(91.4 %id)
CV366550 uterus .a 3464 to 3551 20 to 107       88/107
(82 %)
6 diff
(94.4 %id)
BE539033 cervix .a 3467 to 3915 1 to 448   AAA   448/448
(100 %)
4 diff
(99.2 %id)
AA902279 pooled germ cell tumors .a 3468 to 3916 456 to 8       449/456
(98 %)
0 diff
(100 %id)
AW780057 colon, moderately-differentiated adenocarcinoma .a 3469 to 3916 454 to 9       446/454
(98 %)
0 diff
(100 %id)
AW374359 colon .a 3471 to 3840 372 to 3       370/374
(98 %)
0 diff
(100 %id)
DB523539 testis .a 3471 to 3907 1 to 437     Submitted on the opposite strand 437/439
(99 %)
1 diff
(99.8 %id)
AI361207 brain, glioblastoma (pooled) .a 3481 to 3916 439 to 3       437/443
(98 %)
0 diff
(100 %id)
AA370523 Prostate .a 3502 to 3873 1 to 374       374/375
(99 %)
3 diff
(99.2 %id)
TI_157599233   .a 3503 to 4064 672 to 111       562/672
(83 %)
0 diff
(100 %id)
AA918303 pooled .a 3505 to 3916 417 to 3       415/417
(99 %)
0 diff
(100 %id)
AI806121 pooled .a 3508 to 3916 412 to 4       409/412
(99 %)
0 diff
(100 %id)
AI219723 pooled .a 3512 to 3916 412 to 8       405/412
(98 %)
0 diff
(100 %id)
BG057391 blood, lymphocyte .a 3512 to 4013 508 to 6       503/508
(99 %)
0 diff
(100 %id)
TI_1948244085   .a 3513 to 4444 1134 to 191   AAA   944/1464
(64 %)
0 diff
(100 %id)
AW172660 pooled .a 3518 to 3916 403 to 4       400/403
(99 %)
0 diff
(100 %id)
AA917804 pooled .a 3519 to 3916 405 to 8       398/405
(98 %)
0 diff
(100 %id)
TI_149300163   .a 3519 to 4165 700 to 59       642/859
(74 %)
0 diff
(100 %id)
BM785326 stomach .a 3526 to 3916 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
BU676977 lung, Primary Lung Epithelial Cells .a 3529 to 3915 405 to 19   AAA   387/387
(100 %)
8 diff
(98.0 %id)
AA724312 pooled .a 3531 to 3916 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AA389649   .a 3539 to 3708 1 to 173       173/173
(100 %)
4 diff
(97.7 %id)
TI_157605547   .a 3539 to 4052 597 to 84       514/598
(85 %)
0 diff
(100 %id)
BE535187 cervix .a 3542 to 3912 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BM474474 leiomyosarcoma, uterus .a 3555 to 4436 1 to 882   AAA   882/882
(100 %)
5 diff
(99.5 %id)
W21444 lung .a 3559 to 3949 1 to 397       397/397
(100 %)
6 diff
(98.5 %id)
FN157575 breast carcinoma .a 3571 to 3670 104 to 1     Submitted on the opposite strand 104/105
(99 %)
4 diff
(96.2 %id)
W67307 heart .a 3574 to 3909 341 to 1   fully sequenced,   341/341
(100 %)
3 diff
(99.2 %id)
FN114804 breast carcinoma .a 3577 to 3678 1 to 104       104/105
(99 %)
3 diff
(97.2 %id)
AA345461 gall bladder .a 3578 to 3822 1 to 245       245/245
(100 %)
0 diff
(100 %id)
AW172579 pooled .a 3580 to 3909 341 to 13   AAA   329/329
(100 %)
2 diff
(99.4 %id)
AA913323 pooled .a 3585 to 3916 337 to 3       335/337
(99 %)
0 diff
(100 %id)
AA345720 gall bladder .a 3590 to 3819 1 to 233       233/233
(100 %)
2 diff
(99.2 %id)
AA343748 gall bladder .a 3592 to 3819 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
AA343927 gall bladder .a 3592 to 3926 1 to 335       335/335
(100 %)
0 diff
(100 %id)
AA344000 gall bladder .a 3592 to 3846 1 to 255       255/255
(100 %)
0 diff
(100 %id)
AA344775 gall bladder .a 3592 to 3774 1 to 183       183/183
(100 %)
0 diff
(100 %id)
BE464813 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3597 to 4045 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AW050495 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3599 to 3915 317 to 1       317/317
(100 %)
0 diff
(100 %id)
FN056776 breast carcinoma .a 3606 to 3699 1 to 94       94/94
(100 %)
0 diff
(100 %id)
AW195616 pooled .a 3610 to 3915 316 to 11   AAA   306/306
(100 %)
1 diff
(99.7 %id)
AW080024 pooled .a 3611 to 3916 309 to 4       306/309
(99 %)
0 diff
(100 %id)
BQ007484 placenta .a 3620 to 4064 462 to 18   AAA   445/445
(100 %)
1 diff
(99.8 %id)
FN064660 breast carcinoma .a 3625 to 3721 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
AA352064   .a 3641 to 3915 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AA357864 lung .a 3641 to 3915 1 to 275       275/275
(100 %)
0 diff
(100 %id)
AI620625 Prostate .a 3643 to 3915 283 to 11   AAA   273/273
(100 %)
0 diff
(100 %id)
CF529041 placenta .a 3653 to 4064 431 to 20       412/431
(95 %)
0 diff
(100 %id)
CB850807 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3653 to 4165 530 to 18       513/530
(96 %)
0 diff
(100 %id)
BM714277 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3654 to 4203 1 to 550   fully sequenced,   550/550
(100 %)
0 diff
(100 %id)
TI_1948244603   .a 3655 to 4444 960 to 189   AAA   772/1328
(58 %)
0 diff
(100 %id)
CF529709 placenta .a 3656 to 4052 408 to 12       397/408
(97 %)
0 diff
(100 %id)
AI864124 pooled .a 3659 to 3916 264 to 8       257/264
(97 %)
0 diff
(100 %id)
BQ011313 placenta .a 3677 to 4052 387 to 12       376/387
(97 %)
0 diff
(100 %id)
FN090631 breast carcinoma .a 3679 to 3785 104 to 1     Submitted on the opposite strand 104/106
(98 %)
3 diff
(97.2 %id)
BQ012003 placenta .a 3679 to 3915 257 to 19   AAA   239/239
(100 %)
2 diff
(99.2 %id)
BM931994 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3689 to 4045 1 to 357   AAA   357/357
(100 %)
0 diff
(100 %id)
FN153408 breast carcinoma .a 3700 to 3818 115 to 1     Submitted on the opposite strand 115/115
(100 %)
7 diff
(94.0 %id)
BF448932 sympathetic trunk .a 3700 to 4046 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
BQ011803 placenta .a 3707 to 3915 229 to 19   AAA   211/211
(100 %)
3 diff
(98.6 %id)
TI_1948244342   .a 3709 to 4444 920 to 175   AAA   746/1351
(55 %)
0 diff
(100 %id)
FN146163 breast carcinoma .a 3712 to 3839 1 to 124       124/125
(99 %)
8 diff
(93.6 %id)
AI587376 adenocarcinoma, Pancreas .a 3760 to 4152 396 to 1       396/396
(100 %)
3 diff
(99.3 %id)
AW189631 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3761 to 3911 154 to 4       151/154
(98 %)
0 diff
(100 %id)
BX119012 melanocyte .a 3806 to 4410 126 to 730       702/731
(96 %)
9 diff
(98.8 %id)
N32666 melanocyte .a 3806 to 4092 126 to 415   fully sequenced,   387/387
(100 %)
15 diff
(96.2 %id)
AW973462   .a 3811 to 4416 606 to 1     Submitted on the opposite strand 606/608
(99 %)
3 diff
(99.6 %id)
AW885544 ovary .a 3817 to 4274 461 to 1       461/484
(95 %)
23 diff
(95.3 %id)
CV573547 cornea, eye .a 3836 to 4322 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
TI_149282472   .a 3851 to 4436 119 to 706   AAA Submitted on the opposite strand 588/706
(83 %)
6 diff
(99.2 %id)
BU607943 Human Lung Epithelial cells, lung .a 3857 to 4436 1 to 580   AAA Submitted on the opposite strand 580/580
(100 %)
4 diff
(99.4 %id)
BU679872 lung, Primary Lung Epithelial Cells .a 3858 to 4436 1 to 579   AAA Submitted on the opposite strand 579/579
(100 %)
3 diff
(99.5 %id)
BU685402 lung, Primary Lung Epithelial Cells .a 3858 to 4436 1 to 579   AAA Submitted on the opposite strand 579/579
(100 %)
3 diff
(99.5 %id)
AW801672 uterus .a 3888 to 4352 472 to 9       464/472
(98 %)
0 diff
(100 %id)
AW589454 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3890 to 4237 363 to 16   AAA   348/348
(100 %)
2 diff
(99.5 %id)
AW801750 uterus .a 3899 to 4352 460 to 9       452/460
(98 %)
0 diff
(100 %id)
AW195743 pooled .a 3933 to 4444 512 to 1       512/512
(100 %)
5 diff
(99.1 %id)
AW173648 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3939 to 4436 511 to 13   AAA   499/499
(100 %)
2 diff
(99.6 %id)
AI435597 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3945 to 4448 504 to 1       504/504
(100 %)
1 diff
(99.9 %id)
AA587203 colon, colon tumor RER+ .a 3953 to 4040 88 to 1       88/88
(100 %)
0 diff
(100 %id)
N93403 lung .a 3959 to 4437 499 to 1       499/499
(100 %)
63 diff
(87.4 %id)
AA769111 germinal center B cell .a 3962 to 4436 492 to 18   AAA   475/475
(100 %)
0 diff
(100 %id)
BQ005050 Chondrosarcoma, Left Pelvis .a 3968 to 4436 486 to 19   AAA   468/468
(100 %)
4 diff
(99.2 %id)
FN143310 breast carcinoma .a 3974 to 4036 64 to 1     Submitted on the opposite strand 64/64
(100 %)
1 diff
(98.5 %id)
AW167197 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3974 to 4045 1 to 72   AAA Submitted on the opposite strand 72/72
(100 %)
0 diff
(100 %id)
AI445634 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3975 to 4444 471 to 2       470/471
(99 %)
0 diff
(100 %id)
AA609188   .a 3977 to 4423 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AI214039 astrocytoma, brain .a 3981 to 4386 406 to 1       406/406
(100 %)
1 diff
(99.8 %id)
N24574 melanocyte .a 3985 to 4322 341 to 1       341/341
(100 %)
9 diff
(97.4 %id)
AI276162 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3998 to 4448 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
BM144549 leukopheresis .a 4018 to 4444 435 to 9       427/435
(98 %)
0 diff
(100 %id)
AA766041 germinal center B cell .a 4059 to 4444 392 to 7       386/392
(98 %)
0 diff
(100 %id)
AI804798 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4060 to 4441 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
AA548828 colon, tumor .a 4062 to 4411 355 to 6       350/355
(98 %)
0 diff
(100 %id)
FN056485 breast carcinoma .a 4065 to 4128 65 to 1     Submitted on the opposite strand 65/66
(98 %)
1 diff
(98.5 %id)
AI888357 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4065 to 4436 389 to 18   AAA   372/372
(100 %)
4 diff
(99.0 %id)
AI143952   .a 4066 to 4438 375 to 3       373/375
(99 %)
0 diff
(100 %id)
TI_153988555   .a 4067 to 4441 472 to 98   AAA   375/375
(100 %)
2 diff
(99.5 %id)
AI251116 adenocarcinoma, Pancreas .a 4073 to 4438 369 to 4       366/369
(99 %)
0 diff
(100 %id)
N23291 melanocyte .a 4085 to 4436 353 to 1   fully sequenced,   353/353
(100 %)
3 diff
(99.2 %id)
FN050750 breast carcinoma .a 4086 to 4198 1 to 113       113/113
(100 %)
0 diff
(100 %id)
AW204776   .a 4087 to 4441 372 to 18   AAA   355/355
(100 %)
2 diff
(99.5 %id)
BP397410 pancreatic islet .a 4094 to 4440 1 to 348     Submitted on the opposite strand 348/350
(99 %)
2 diff
(99.5 %id)
BP396542 pancreatic islet .a 4094 to 4569 1 to 476     Submitted on the opposite strand 476/480
(99 %)
6 diff
(98.8 %id)
BE220761 malignant melanoma, metastatic to lymphnode, skin .a 4095 to 4441 347 to 1       347/347
(100 %)
1 diff
(99.8 %id)
BG460514   .a 4102 to 4529 437 to 1     Submitted on the opposite strand 437/544
(80 %)
14 diff
(97.5 %id)
AA659138 alveolar rhabdomyosarcoma .a 4128 to 4439 312 to 1       312/318
(98 %)
1 diff
(99.7 %id)
AA648949 germinal center B cell .a 4152 to 4436 313 to 29   AAA   285/285
(100 %)
0 diff
(100 %id)
AA189170   .a 4157 to 4438 285 to 4       282/287
(98 %)
0 diff
(100 %id)
BU739054 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4173 to 4437 283 to 19   fully sequenced, AAA   265/265
(100 %)
1 diff
(99.7 %id)
AI284068 colon, moderately-differentiated adenocarcinoma .a 4207 to 4439 261 to 29   AAA   233/233
(100 %)
3 diff
(98.8 %id)
BP422723 small intestine .a 4223 to 4438 1 to 216     Submitted on the opposite strand 216/218
(99 %)
2 diff
(99.1 %id)
EC579233 Prostate .a 4254 to 4379 1 to 122       122/122
(100 %)
4 diff
(96.8 %id)
AI540359 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 4286 to 4436 151 to 1       151/151
(100 %)
1 diff
(99.4 %id)
AI608781 normal gingiva (cell line from immortalizedkeratinocytes) .a 4327 to 4916 606 to 17   tiling clone, AAA   590/590
(100 %)
3 diff
(99.5 %id)
BI021151 marrow .a 4364 to 4478 1 to 115       115/117
(98 %)
3 diff
(97.5 %id)
FN124455 breast carcinoma .a 4372 to 4437 1 to 66       66/67
(98 %)
1 diff
(98.6 %id)
NM_032560.4   .b 1 to 3894 1 to 3894 exact RefSeq,   3894/3894
(100 %)
0 diff
(100 %id)
BM147425 leukopheresis .b 1 to 531 1 to 530   tiling clone,   530/531
(99 %)
2 diff
(99.7 %id)
BM149219 leukopheresis .b 1 to 482 1 to 482       482/489
(98 %)
4 diff
(99.2 %id)
BM149932 leukopheresis .b 1 to 376 1 to 376       376/398
(94 %)
12 diff
(97.0 %id)
BM150155 leukopheresis .b 1 to 322 1 to 321       321/336
(95 %)
15 diff
(95.6 %id)
DA819787   .b 3 to 570 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA692848   .b 15 to 573 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB079574 testis .b 15 to 585 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB054610 testis .b 17 to 588 2 to 577   capped   576/576
(100 %)
7 diff
(98.8 %id)
DA792467 brain .b 30 to 586 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DN994060 brain, whole brain .b 232 to 982 9 to 759       751/759
(98 %)
12 diff
(98.5 %id)
DN998527 bone marrow .b 232 to 819 8 to 595       588/595
(98 %)
8 diff
(98.7 %id)
AW840163 leiomios .b 318 to 744 1 to 427       427/427
(100 %)
2 diff
(99.6 %id)
AA333199 Embryo, 8 weeks .b 349 to 693 1 to 351       351/353
(99 %)
10 diff
(97.2 %id)
CD557718 testis .b 350 to 1159 23 to 839       817/893
(91 %)
23 diff
(97.5 %id)
CN398459 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 397 to 1094 1 to 697   tiling clone,   697/697
(100 %)
1 diff
(99.9 %id)
DA523342 brain .b 404 to 972 2 to 570   capped   569/570
(99 %)
2 diff
(99.7 %id)
DA149861 amygdala .b 430 to 1007 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA364385 subthalamic nucleus .b 435 to 983 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BM541764 leiomyosarcoma, uterus .b 481 to 1344 58 to 927       868/1142
(76 %)
16 diff
(98.6 %id)
CV569629 cornea, eye .b 556 to 1158 1 to 603       603/603
(100 %)
0 diff
(100 %id)
DB073049 testis .b 561 to 1107 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
AK024297   .b 574 to 3365 1 to 2794   available from FLJ,   2794/2794
(100 %)
6 diff
(99.8 %id)
AU132599   .b 575 to 1246 2 to 672   capped   671/675
(99 %)
11 diff
(98.4 %id)
DA187018 amygdala .b 615 to 1173 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA309889 hippocampus .b 617 to 1188 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA309917 hippocampus .b 617 to 1194 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
AW500135 lymph .b 658 to 1096 1 to 440       440/440
(100 %)
7 diff
(98.5 %id)
TI_154154263   .b 664 to 1317 79 to 731       653/657
(99 %)
20 diff
(97.0 %id)
DA277982 corpus callosum .b 693 to 1241 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA714052   .b 789 to 1362 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA567739   .b 830 to 1383 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
AI750780 Bone, Hip .b 842 to 1292 15 to 465       451/465
(96 %)
6 diff
(98.8 %id)
BU429570 lymph .b 856 to 1415 1 to 560       560/560
(100 %)
6 diff
(99.0 %id)
TI_154149093   .b 863 to 1506 83 to 724       642/724
(88 %)
28 diff
(96.2 %id)
TI_154150647   .b 863 to 1514 77 to 728       652/801
(81 %)
5 diff
(99.4 %id)
CX782932 human embryonic stem cells .b 912 to 1611 1 to 700   tiling clone,   700/700
(100 %)
0 diff
(100 %id)
BQ953394 leiomyosarcoma, uterus .b 958 to 1527 1 to 573       573/1058
(54 %)
24 diff
(97.8 %id)
DB245705 uterus, tumor tissue .b 961 to 1523 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB094431 testis .b 969 to 1516 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BE537069 cervix .b 984 to 1724 1 to 736       738/875
(84 %)
42 diff
(95.2 %id)
BG287316 bladder, transitional cell papilloma, cell line .b 1044 to 1590 1 to 564       562/1085
(51 %)
32 diff
(97.1 %id)
BG436274 placenta .b 1068 to 1792 1 to 717       722/725
(99 %)
23 diff
(96.9 %id)
BG621703 placenta .b 1177 to 2020 1 to 844       844/845
(99 %)
19 diff
(97.8 %id)
BF326822 breast_normal .b 1247 to 1759 1 to 513       513/513
(100 %)
5 diff
(99.1 %id)
AW995328 breast_normal .b 1254 to 1792 1 to 539       539/539
(100 %)
1 diff
(99.9 %id)
BM555380 duodenal adenocarcinoma, cell line, small intestine .b 1262 to 2075 1 to 816       816/1122
(72 %)
8 diff
(99.3 %id)
BU170990 eye, retinoblastoma .b 1379 to 2217 1 to 842       842/863
(97 %)
15 diff
(98.3 %id)
BF036644 adenocarcinoma, ovary .b 1386 to 2057 1 to 657       657/919
(71 %)
21 diff
(97.8 %id)
CX781498 human embryonic stem cells .b 1401 to 2240 1 to 840       840/840
(100 %)
0 diff
(100 %id)
CD171822 testis .b 1500 to 2281 1 to 785       785/810
(96 %)
6 diff
(99.3 %id)
DT220047 brain .b 1513 to 1869 1 to 357       357/357
(100 %)
3 diff
(99.2 %id)
TI_57166090   .b 1535 to 2285 29 to 779   tiling clone,   751/779
(96 %)
6 diff
(99.3 %id)
BI835430 pooled pancreas and spleen .b 1537 to 2285 1 to 749       749/749
(100 %)
0 diff
(100 %id)
CN398462 embryonic stem cells, cell lines H1, H7, andH9 .b 1573 to 2186 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BG434364 placenta .b 1577 to 2281 1 to 705       705/706
(99 %)
20 diff
(97.2 %id)
W07704 lung .b 1616 to 2078 1 to 467       467/473
(98 %)
7 diff
(98.6 %id)
CR605708 Neuroblastoma Cot 25-normalized .b 1715 to 3353 1 to 1639   tiling clone,   1639/1639
(100 %)
0 diff
(100 %id)
BX375501 Neuroblastoma Cot 25-normalized .b 1715 to 2604 1 to 889       889/889
(100 %)
5 diff
(99.5 %id)
BX388397 Neuroblastoma Cot 25-normalized .b 1715 to 2731 1 to 1014       1014/1014
(100 %)
6 diff
(99.5 %id)
AU254009 neuroblastoma .b 1754 to 2408 26 to 682       657/700
(93 %)
8 diff
(98.9 %id)
BE000761 breast_normal .b 1764 to 2026 261 to 2     Submitted on the opposite strand 260/269
(96 %)
1 diff
(99.7 %id)
DA028155   .b 1776 to 2338 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BX429649 neuroblastoma .b 1795 to 2690 1 to 890       890/894
(99 %)
15 diff
(98.4 %id)
AL696269 human skeletal muscle .b 1831 to 2421 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DA358211 subthalamic nucleus .b 1919 to 2496 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
AW393113 stomach .b 1940 to 2575 640 to 6       635/640
(99 %)
10 diff
(98.5 %id)
AI638670 pooled germ cell tumors .b 1952 to 2408 458 to 2       457/458
(99 %)
3 diff
(99.4 %id)
CU446122 epidermis .b 1958 to 2706 760 to 11     Submitted on the opposite strand 750/760
(98 %)
2 diff
(99.8 %id)
TI_1948139867   .b 1962 to 2745 926 to 140       787/1278
(61 %)
21 diff
(98.4 %id)
CD641789 pooled .b 1967 to 2634 1 to 665       665/716
(92 %)
11 diff
(98.5 %id)
AI953415 normal epithelium, ovary .b 1980 to 2396 417 to 1       417/418
(99 %)
2 diff
(99.6 %id)
CB267466 adipose .b 2011 to 2261 1 to 249       249/249
(100 %)
4 diff
(98.4 %id)
BE178092 head_neck .b 2012 to 2674 13 to 672       660/672
(98 %)
12 diff
(98.3 %id)
TI_1948139372   .b 2067 to 2740 676 to 2       675/1049
(64 %)
10 diff
(99.1 %id)
TI_57180654   .b 2081 to 2974 34 to 939       906/939
(96 %)
25 diff
(97.4 %id)
CN398463 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2083 to 2700 9 to 628       620/628
(98 %)
8 diff
(98.8 %id)
BI768202 pooled lung and spleen .b 2083 to 2974 1 to 904       904/904
(100 %)
19 diff
(97.9 %id)
BG166868 hypernephroma, cell line, Kidney .b 2128 to 2896 1 to 770       770/941
(81 %)
23 diff
(97.6 %id)
CX781615 human embryonic stem cells .b 2130 to 2983 1 to 854       854/854
(100 %)
1 diff
(99.9 %id)
CN398458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2173 to 2765 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BG676909 skin, squamous cell carcinoma .b 2184 to 3029 1 to 849       849/857
(99 %)
8 diff
(99.1 %id)
TI_1948139619   .b 2216 to 2745 663 to 133       531/1321
(40 %)
11 diff
(99.2 %id)
TI_1948139373   .b 2217 to 2745 655 to 123       533/1409
(37 %)
21 diff
(98.6 %id)
CB156944 Liver .b 2230 to 2756 1 to 536       545/536
(101 %)
57 diff
(89.4 %id)
BX388396 Neuroblastoma Cot 25-normalized .b 2289 to 3353 1056 to 1       1056/1061
(99 %)
12 diff
(98.9 %id)
BE177929 head_neck .b 2290 to 2751 461 to 5     Submitted on the opposite strand 457/462
(98 %)
5 diff
(99.0 %id)
AU142935   .b 2297 to 3107 2 to 810   capped   809/819
(98 %)
7 diff
(99.2 %id)
BG756249 B-cells, primary B-cells from tonsils (cell line) .b 2320 to 2938 1 to 619   available from MGC,   619/619
(100 %)
1 diff
(99.9 %id)
BC018617 Primary B-Cells from Tonsils .b 2321 to 3365 1 to 1045   available from MGC, AAA   1045/1045
(100 %)
0 diff
(100 %id)
BE539957 cervix .b 2357 to 3091 1 to 738       738/738
(100 %)
16 diff
(97.9 %id)
BP228161   .b 2360 to 2909 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BF185052 bone marrow, from chronic myelogenous leukemia .b 2363 to 2972 1 to 624       624/1122
(55 %)
28 diff
(97.6 %id)
CR979528 T-Lymphocytes .b 2380 to 3034 1 to 657       657/657
(100 %)
2 diff
(99.7 %id)
FN086130 breast carcinoma .b 2449 to 2559 108 to 1     Submitted on the opposite strand 108/108
(100 %)
3 diff
(97.3 %id)
FN145704 breast carcinoma .b 2466 to 2574 106 to 1     Submitted on the opposite strand 106/106
(100 %)
4 diff
(96.3 %id)
AU154104   .b 2816 to 3365 553 to 1       553/553
(100 %)
8 diff
(98.6 %id)
CX782854 human embryonic stem cells .b 2823 to 3365 569 to 27   AAA   543/554
(98 %)
1 diff
(99.9 %id)
AU254010 neuroblastoma .b 2826 to 3497 700 to 30   tiling clone,   671/700
(95 %)
0 diff
(100 %id)
N80582 lung .b 2916 to 3359 445 to 1       445/446
(99 %)
1 diff
(99.8 %id)
DB384354   .b 3408 to 3889 481 to 1   tiling clone,   481/536
(89 %)
6 diff
(98.9 %id)
BX248247 neuroblastoma .c 1 to 2412 1 to 2412 exact tiling clone,   2412/2412
(100 %)
0 diff
(100 %id)
BX446729 neuroblastoma .c 1 to 1044 1 to 1040       1040/1040
(100 %)
5 diff
(99.6 %id)
DA803637 brain .c 79 to 641 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA993080 synovial membrane tissue from rheumatioidarthritis .d 1 to 472 2 to 473   tiling clone, capped   472/472
(100 %)
1 diff
(99.8 %id)
DA500272 brain .d 3 to 507 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
CN418447 embryonic stem cells, cell lines H1, H7, andH9 .d 10 to 363 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
DB458050 testis .d 15 to 513 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
CR991613 T-Lymphocytes .d 19 to 652 1 to 634       634/634
(100 %)
0 diff
(100 %id)
AW503383 lymph .d 33 to 164 1 to 132       132/132
(100 %)
6 diff
(95.5 %id)
CA391914 eye, RPE/choroid .d 36 to 458 1 to 423       423/423
(100 %)
0 diff
(100 %id)
BC038932 Eye, retinoblastoma .d 57 to 3282 12 to 3237   tiling clone, available from MGC, AAA   3226/3226
(100 %)
1 diff
(100.0 %id)
BE890585 melanotic melanoma, skin .d 69 to 302 1 to 232   available from MGC,   232/232
(100 %)
2 diff
(99.2 %id)
CN418448 embryonic stem cells, cell lines H1, H7, andH9 .d 91 to 228 1 to 138       138/138
(100 %)
1 diff
(99.3 %id)
CN418449 embryonic stem cells, cell lines H1, H7, andH9 .d 92 to 519 1 to 428       428/428
(100 %)
2 diff
(99.6 %id)
DA925299 small intestine .d 222 to 555 2 to 335   capped   334/334
(100 %)
0 diff
(100 %id)
DB099570 testis .d 222 to 755 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
BU430877 lymph .d 225 to 507 1 to 283       283/283
(100 %)
4 diff
(98.6 %id)
DB284765 uterus .d 228 to 487 2 to 262   capped   261/261
(100 %)
1 diff
(99.7 %id)
DA503974 brain .d 229 to 544 2 to 317   capped   316/316
(100 %)
0 diff
(100 %id)
BG899889 cartilage .d 230 to 557 85 to 412       328/344
(95 %)
6 diff
(98.3 %id)
TI_154152428   .d 230 to 772 79 to 624       546/550
(99 %)
26 diff
(95.3 %id)
CR994589 T-Lymphocytes .d 231 to 765 1 to 535       535/536
(99 %)
1 diff
(99.9 %id)
BQ229254 embryonal carcinoma, cell line, testis .d 237 to 956 1 to 728       728/947
(76 %)
19 diff
(98.0 %id)
DA112719 cerebellum .d 240 to 651 2 to 413   capped   412/412
(100 %)
0 diff
(100 %id)
TI_1948139371   .d 878 to 1662 125 to 913       789/1292
(61 %)
18 diff
(98.7 %id)
TI_1948139618   .d 878 to 1616 110 to 851       742/1294
(57 %)
10 diff
(99.3 %id)
CV030850 mixed .d 879 to 1451 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
TI_1948139370   .d 879 to 1662 119 to 900       782/1278
(61 %)
13 diff
(99.0 %id)
TI_1948139617   .d 879 to 1661 130 to 907       778/1259
(61 %)
24 diff
(98.1 %id)
TI_1948139865   .d 879 to 1563 123 to 807       685/1292
(53 %)
16 diff
(98.8 %id)
TI_1948139866   .d 879 to 1722 130 to 979       848/1257
(67 %)
28 diff
(97.8 %id)
TI_1948140126   .d 879 to 1770 121 to 1022       901/1329
(67 %)
43 diff
(96.8 %id)
TI_1948140127   .d 880 to 1563 130 to 814       685/1229
(55 %)
21 diff
(98.3 %id)
AL044714 testis .d 1277 to 1766 1 to 490       490/490
(100 %)
0 diff
(100 %id)
CA391913 eye, RPE/choroid .d 2841 to 3282 468 to 26   AAA   443/443
(100 %)
3 diff
(99.4 %id)
CD512563 Pooled-Skin .e 1 to 749 1 to 757   tiling clone,   757/757
(100 %)
13 diff
(98.3 %id)
BU198353   .e 263 to 821 1 to 559       559/560
(99 %)
5 diff
(99.2 %id)
BU198640   .e 263 to 1174 1 to 910       910/1102
(82 %)
21 diff
(98.1 %id)
CX871972 embryonic stem .e 307 to 930 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BX367749 Neuroblastoma Cot 25-normalized .e 403 to 1283 1 to 882       884/883
(100 %)
18 diff
(98.0 %id)
TI_1948140128   .e 406 to 918 682 to 156       527/1337
(39 %)
45 diff
(96.7 %id)
AL832921 melanoma (MeWo cell line) .e 415 to 2064 1 to 1649   tiling clone, available from DKFZ, AAA   1649/1649
(100 %)
1 diff
(100.0 %id)
BP207977 coronary artery .e 422 to 994 1 to 573       573/582
(98 %)
3 diff
(99.5 %id)
BP200985 amygdala .e 426 to 1008 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AK001885 placenta .f 1 to 1943 2 to 1943 L235F L236* tiling clone, available from FLJ,   1943/1943
(100 %)
2 diff
(99.9 %id)
AU136222 placenta .f 1 to 758 2 to 761   to resequence, capped   760/760
(100 %)
10 diff
(98.7 %id)
DA739908   .f 202 to 744 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
CB051961 leiomyosarcoma, soft tissue .f 440 to 994 10 to 561   fully sequenced,   552/561
(98 %)
6 diff
(99.0 %id)
BE185718 head_neck .f 688 to 987 8 to 307       300/307
(97 %)
6 diff
(98.1 %id)
BE185845 head_neck .f 700 to 1108 417 to 8   tiling clone, Submitted on the opposite strand 410/417
(98 %)
0 diff
(100 %id)
DB016130 esophageal, tumor tissue .f 798 to 1369 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
CB051960 leiomyosarcoma, soft tissue .f 964 to 1514 574 to 24   fully sequenced, AAA   551/551
(100 %)
1 diff
(99.9 %id)
CV571375 cornea, eye .f 997 to 1128 1 to 132       132/132
(100 %)
2 diff
(98.5 %id)
AW449876   .f 1064 to 1514 468 to 18   AAA   451/451
(100 %)
1 diff
(99.8 %id)
BM853545 Ascites, stomach .f 1190 to 1798 1 to 609       609/609
(100 %)
0 diff
(100 %id)
AU156579 placenta .f 1365 to 1943 577 to 1   to resequence,   577/577
(100 %)
31 diff
(94.7 %id)
FN064437 breast carcinoma .f 1378 to 1498 1 to 121       121/121
(100 %)
0 diff
(100 %id)
AW779151 pooled .f 1509 to 1944 451 to 1       451/534
(84 %)
25 diff
(95.4 %id)
BX093036 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1516 to 1957 441 to 1   tiling clone, Submitted on the opposite strand 441/453
(97 %)
1 diff
(99.8 %id)
AI366909 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 1517 to 1950 434 to 1       434/438
(99 %)
1 diff
(99.8 %id)
AI750781 Bone, Hip .f 1523 to 1894 379 to 8       372/379
(98 %)
0 diff
(100 %id)
AA564776 low-grade prostatic neoplasia, Prostate .f 1567 to 1949 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AA701874 liver and spleen .f 1609 to 1943 335 to 1       335/335
(100 %)
0 diff
(100 %id)
DA947190 Spleen .f 1784 to 2349 2 to 566   tiling clone, capped   565/565
(100 %)
2 diff
(99.7 %id)
BF920889 nervous_tumor .f 1812 to 2310 507 to 14     Submitted on the opposite strand 494/507
(97 %)
0 diff
(100 %id)
BF922997 nervous_tumor .f 1812 to 2310 507 to 14     Submitted on the opposite strand 494/535
(92 %)
0 diff
(100 %id)
AV706187 adrenal gland .f 2005 to 2798 1 to 785       785/785
(100 %)
22 diff
(97.2 %id)
DB144412 thymus .f 2230 to 2757 2 to 529   tiling clone, capped   528/528
(100 %)
0 diff
(100 %id)
CB985162 Pooled-Glandular .f 2355 to 3046 1 to 701       701/778
(90 %)
15 diff
(98.1 %id)
DB094017 testis .f 2425 to 2967 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
CB269777 adipose .f 2635 to 3123 1 to 491   tiling clone,   491/491
(100 %)
1 diff
(99.8 %id)
AI923248 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 2646 to 3154 1 to 511     Submitted on the opposite strand 511/516
(99 %)
4 diff
(99.3 %id)
AA307780 colon .f 2823 to 3199 1 to 377   tiling clone,   377/377
(100 %)
0 diff
(100 %id)
DB333581 Spleen .f 3880 to 4433 554 to 1   tiling clone,   554/554
(100 %)
2 diff
(99.7 %id)
AL702941 human skeletal muscle .g 1 to 590 1 to 594 F6X S7X E9X R28X K29X ... tiling clone,   594/600
(99 %)
7 diff
(98.9 %id)
BM802753 embryonal carcinoma, cell line, testis .h 1 to 1110 1 to 1115 exact tiling clone,   1114/1118
(99 %)
60 diff
(94.7 %id)
DB053139 testis .h 293 to 860 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BY795164 eye .h 340 to 1472 1 to 1133   tiling clone,   1133/1133
(100 %)
2 diff
(99.9 %id)
CN398461 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 487 to 1214 9 to 736       728/736
(98 %)
6 diff
(99.2 %id)
BF843917 head_neck .h 542 to 933 1 to 392       392/392
(100 %)
10 diff
(97.5 %id)
BF844535 head_neck .h 591 to 762 10 to 183       174/183
(95 %)
4 diff
(97.9 %id)
DA203884 brain .h 637 to 1206 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CN398460 embryonic stem cells, DMSO-treated H9 cellline .h 649 to 1175 1 to 527       527/527
(100 %)
1 diff
(99.9 %id)
DB127689 thymus .i 1 to 533 2 to 534 exact tiling clone, capped   533/533
(100 %)
0 diff
(100 %id)
BG398898 Kidney .j 1 to 657 1 to 660   tiling clone,   660/665
(99 %)
10 diff
(98.5 %id)
BG548848 lung .j 397 to 1215 1 to 833 exact tiling clone,   833/858
(97 %)
23 diff
(97.4 %id)
CB136119 Liver .j 474 to 1043 7 to 576       570/576
(98 %)
1 diff
(99.9 %id)
BX425347 neuroblastoma .j 487 to 1431 942 to 1       942/942
(100 %)
44 diff
(95.4 %id)
TI_149306080   .j 530 to 1430 976 to 90   AAA   885/939
(94 %)
29 diff
(97.0 %id)
AI904425 breast .j 563 to 1272 707 to 1       707/711
(99 %)
7 diff
(99.1 %id)
TI_154110478   .j 588 to 1430 913 to 77   AAA   837/938
(89 %)
22 diff
(97.7 %id)
FN144005 breast carcinoma .j 612 to 716 1 to 105       105/105
(100 %)
5 diff
(95.3 %id)
BM930427 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 644 to 904 1 to 264   fully sequenced,   264/264
(100 %)
4 diff
(98.5 %id)
BG941536 blood .j 651 to 937 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BF239007 bone marrow, from chronic myelogenous leukemia .j 656 to 1316 1 to 668       668/784
(85 %)
26 diff
(96.7 %id)
BC028088 Cervix, carcinoma .j 663 to 1956 12 to 1305   tiling clone, available from MGC, AAA   1294/1294
(100 %)
0 diff
(100 %id)
TI_1948244083   .j 663 to 1549 168 to 1048       881/1274
(69 %)
19 diff
(98.6 %id)
TI_1948244084   .j 663 to 1345 175 to 865       691/1155
(59 %)
40 diff
(96.6 %id)
TI_1948244340   .j 663 to 1559 178 to 1069       892/1243
(71 %)
18 diff
(98.6 %id)
TI_1948244600   .j 663 to 1587 172 to 1089       918/1258
(72 %)
39 diff
(96.9 %id)
TI_1948244601   .j 663 to 1365 187 to 904       718/1255
(57 %)
31 diff
(97.6 %id)
TI_1948244865   .j 663 to 1590 172 to 1092       921/1264
(72 %)
23 diff
(98.2 %id)
TI_1948244866   .j 663 to 1302 197 to 842       646/1253
(51 %)
17 diff
(98.7 %id)
TI_1948244341   .j 670 to 1385 213 to 933       721/1144
(63 %)
21 diff
(98.2 %id)
BQ018507 lung, Metastatic Chondrosarcoma .j 677 to 1430 770 to 19   AAA   752/752
(100 %)
6 diff
(99.3 %id)
BE544159 cervical carcinoma cell line, cervix .j 684 to 1381 1 to 692   available from MGC,   692/774
(89 %)
14 diff
(98.2 %id)
BU743115 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .j 874 to 1430 575 to 19   fully sequenced, AAA   557/557
(100 %)
1 diff
(99.9 %id)
BX482653   .k-u 1 to 682 1 to 684 C12L D13V Q15R F16S T17L ... tiling clone,   684/684
(100 %)
7 diff
(99.0 %id)
DA372326 thalamus .k-u 622 to 1178 2 to 558   tiling clone, capped   557/557
(100 %)
5 diff
(99.2 %id)
DA949341 Spleen .k-u 990 to 1542 2 to 552   tiling clone, capped   551/551
(100 %)
6 diff
(99.0 %id)
AV704147 adrenal gland Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV703410 adrenal gland Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AK000714 ileal mucosa Gene SMEK1, variant not shown       available from FLJ, AAA Suspected internal deletion, this clone was ignored    
BC072409 Eye, retinoblastoma Gene SMEK1, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BF770311 epid_tumor Gene SMEK1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
F10867 brain, total brain Gene SMEK1, variant not shown              
F13267 brain, total brain Gene SMEK1, variant not shown              
AV712139   Gene SMEK1, variant not shown         Suspected internal deletion, this clone was ignored    
AV692739 hepatocellular carcinoma Gene SMEK1, variant not shown         Suspected internal deletion, this clone was ignored    
AV648819 corresponding non cancerous liver tissue Gene SMEK1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV648831 corresponding non cancerous liver tissue Gene SMEK1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB319255 lung Gene SMEK1, variant not shown         Suspected internal deletion, this clone was ignored    
DA582368 lung Gene SMEK1, variant not shown       capped Suspected internal deletion, this clone was ignored    
BJ993267 hepatoblastoma Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BJ993268 hepatoblastoma Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
R38165 whole brain Gene SMEK1, variant not shown       AAA      
T77084 whole brain Gene SMEK1, variant not shown              
N95135 liver and spleen Gene SMEK1, variant not shown              
BU154017 eye, retinoblastoma Gene SMEK1, variant not shown         Suspected internal deletion, this clone was ignored    
BU854620 testis Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BP382979 ilea mucosa Gene SMEK1, variant not shown         Suspected internal deletion, this clone was ignored    
AV750225 Pituitary Gene SMEK1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB135472 thymus Gene SMEK1, variant not shown       capped This clone was ignored    
DB344955 thymus Gene SMEK1, variant not shown         This clone was ignored    
DB145046 thymus Gene SMEK1, variant not shown       capped      
DB345675 thymus Gene SMEK1, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI